Bailard’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-27,200
| Closed | -$645K | – | 839 |
|
|
2023
Q3 | $645K | Sell |
27,200
-5,500
| -17% | -$104K | 0.02% | 350 |
|
|
2023
Q2 | $530K | Hold |
32,700
| – | – | 0.02% | 386 |
|
|
2023
Q1 | $569K | Buy |
32,700
+2,000
| +7% | +$36K | 0.02% | 368 |
|
|
2022
Q4 | $577K | Sell |
30,700
-1,800
| -6% | -$34.7K | 0.02% | 369 |
|
|
2022
Q3 | $575K | Hold |
32,500
| – | – | 0.02% | 333 |
|
|
2022
Q2 | $567K | Sell |
32,500
-1,900
| -6% | -$36.2K | 0.02% | 352 |
|
|
2022
Q1 | $719K | Hold |
34,400
| – | – | 0.02% | 329 |
|
|
2021
Q4 | $612K | Buy |
34,400
+5,000
| +17% | +$80.3K | 0.02% | 368 |
|
|
2021
Q3 | $415K | Hold |
29,400
| – | – | 0.01% | 441 |
|
|
2021
Q2 | $488K | Buy |
29,400
+1,600
| +6% | +$28.7K | 0.02% | 413 |
|
|
2021
Q1 | $503K | Sell |
27,800
-1,900
| -6% | -$37.5K | 0.02% | 394 |
|
|
2020
Q4 | $542K | Hold |
29,700
| – | – | 0.02% | 307 |
|
|
2020
Q3 | $378K | Buy |
29,700
+4,100
| +16% | +$52.4K | 0.02% | 342 |
|
|
2020
Q2 | $281K | Sell |
25,600
-4,200
| -14% | -$43.5K | 0.02% | 370 |
|
|
2020
Q1 | $311K | Buy |
+29,800
| New | +$384K | 0.02% | 310 |
|
Other funds holding NXGN
Bailard's NXGN Position: Q4 2023 in Review
Bailard sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 27,200 shares — an estimated $645K sold.
Bailard first reported a position in NXGN in Q1 2020 and held it in 15 quarters. The position peaked at $719K in Q1 2022. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Bailard reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Bailard sold 27,200 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $645K.
- Bailard first reported a position in NextGen Healthcare, Inc. Common Stock in Q1 2020 and held it in 15 quarters.
- Bailard's NextGen Healthcare, Inc. Common Stock position peaked at $719K in Q1 2022.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Bailard's 13F filing for Q4 2023, filed 2 Feb 2024.